Tekmira Files for an Injunction in the Supreme Court of British Columbia Seeking Return of Confidential Documents
VANCOUVER, British Columbia, Nov. 16, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, disclosed today that it has filed a Notice of Civil Claim in the Supreme Court of British Columbia against certain individuals from AlCana Technologies, Inc. ("AlCana") alleging that thousands of confidential documents containing Tekmira's confidential information and trade secrets were downloaded and taken from Tekmira. Tekmira also filed a Notice of Application seeking an injunction ordering the documents and derivative materials be returned to Tekmira.
Tekmira discovered the alleged document downloading in the course of producing documents in Tekmira's litigation against Alnylam Pharmaceuticals, Inc. and AlCana in the Massachusetts Superior Court.
In its action, Tekmira alleges that over 10,000 documents containing Tekmira's confidential information and trade secrets were downloaded from Tekmira's electronic document management system and used by AlCana to produce lipids belonging to Tekmira, including the lipid MC3. Tekmira is seeking a pre-trial and permanent mandatory injunction ordering the defendants to surrender all confidential information belonging to Tekmira and an injunction prohibiting the defendants from using or disclosing Tekmira's confidential information to any person or corporation. Tekmira is also seeking general and punitive damages.